[
1. World health organization. WHO-convened global study of origins of SARS-CoV-2: China Part“. World Health Organization. 30 March 2021. www.int.org
]Search in Google Scholar
[
2. Zoumpourlis V, Goulielmaki M, Rizos E, Baliou S, Spandidos D. The COVID-19 pandemic as a scientific and social challenge in the 21st century“. Molecular Medicine Reports. 2020; 22 (4): 3035–3048. doi:10.3892/mmr.2020.11393.
]Search in Google Scholar
[
3. Zhu H, Wei L, Niu P. The novel coronavirus outbreak in Wuhan, China. Global Health Research and Policy. 2020; 5 (1): 6. doi:10.1186/s41256-020-00135-6
]Search in Google Scholar
[
4. Chan JF, Yuan S, Kok KH et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster“. Lancet. 2020; 395 (10223): 514-523. doi:10.1016/S0140-6736(20)30154-9
]Search in Google Scholar
[
5. Maxmen A. WHO report into COVID pandemic origins zeroes in on animal markets, not labs. Nature. 2021; 592 (7853): 173-174.
]Search in Google Scholar
[
6. Perlman S. Another Decade, Another Coronavirus. The New England Journal of Medicine. 2020; 382 (8): 760-762. doi:10.1056/NEJMe2001126.
]Search in Google Scholar
[
7. Page MJ, McKenzie JE, Bossuyt PM et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. doi: 10.1136/bmj.n71
]Search in Google Scholar
[
8. Procopio G, Cancelliere A, Trecarichi EM et al. Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study. Ther Adv Respir Dis. 2020;14:1753466620963016. doi: 10.1177/1753466620963016.
]Search in Google Scholar
[
9. Huq AKMF, Rahman MF, Islam MA, et al. Real-life Management Strategy of COVID-19 Patients in Bangladesh with No Death: An Observational and Cohort Study. Euroasian J Hepato- Gastroenterol 2020; 10(1): 31-35.
]Search in Google Scholar
[
10. Docherty AB, Harrison EM, Green CA, ISARIC4C investigators. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020, 22; 369: m1985. doi: 10.1136/bmj.m1985.
]Search in Google Scholar
[
11. Salvatore CM, Jin-Young H, Acker KP et al. Neonatal management and outcomes during the COVID-19 pandemic: an observation cohort study. Lancet Child Adolesc Health. 2020; 4 (10): 721-727. doi: 10.1016/S2352-4642(20)30235-2
]Search in Google Scholar
[
12. Swann OV, Holden KA, Turtle L et al.. Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans. Nat Microbiol. 2020;5(12):1598-1607. doi: 10.1038/s41564-020-00813-8. Epub 2020 Oct 26.
]Search in Google Scholar
[
13. Santus Р, Tursi F, Croce G et al. Changes in quality of life and dyspnoea after hospitalization in COVID-19 patients discharged at home Multidiscip Respir Med. 2020 13;15(1):713. doi: 10.4081/mrm.2020.713.
]Search in Google Scholar
[
14. Gervasoni С, Meraviglia P, Riv A et al. Clinical Features and Outcomes of Patients With Human Immunodeficiency Virus With COVID-19. Clin Infect Dis. 2020 19;71(16):2276-2278. doi: 10.1093/cid/ciaa579.
]Search in Google Scholar
[
15. Liu R, Yi S, Zhang J et al. Viral Load Dynamics in Sputum and Nasopharyngeal Swab in Patients with COVID-19. J Dent Res. 2020; 99(11):1239-1244. doi: 10.1177/0022034520946251
]Search in Google Scholar
[
16. Molteni Е, Astley CM, Ma W et al. SARS-CoV-2 (COVID-19) infection in pregnant women: characterization of symptoms and syndromes predictive of disease and severity through real-time, remote participatory epidemiology. medRxiv. 2020; 2020.08.17.20161760. doi: 10.1101/2020.08.17.20161760
]Search in Google Scholar
[
17. Bertino Е, Moro GE, De Renz G, Collaborative Research Group on SARS-CoV-2 in Human Milk. Detection of SARSCoV- 2 in Milk From COVID-19 Positive Mothers and Follow- Up of Their Infants. Front Pediatr. 2020; 8: 597699. doi: 10.3389/fped.2020.597699. eCollection 2020.
]Search in Google Scholar
[
18. Snipelisky D, Johnson R, Prasad R et al. Characteristics and Outcomes Based on Perceived Illness Severity in SARSCoV- 2. South Med J. 2020; 113 (12): 618-622. doi: 10.14423/SMJ.0000000000001182.
]Search in Google Scholar
[
19. Bhuyan MAR, Al Mahtab M, Ashab E, et al. Treatment of COVID- 19 Patients at a Medical College Hospital in Bangladesh. Euroasian J Hepato-Gastroenterol 2020;10(1):27-30.
]Search in Google Scholar
[
20. Munblit D, Nekliudov NA, Bugaeva P, Sechenov StopCOVID Research Team. Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection. Clin Infect Dis. 2021; 73 (1): 1-11. doi: 10.1093/cid/ciaa1535.
]Search in Google Scholar
[
21. Hughes HE, Hughes TC, Morbey R et al. Emergency department use during COVID-19 as described by syndromic surveillance. Emerg Med J. 2020; 37(10): 600-604. doi: 10.1136/emermed-2020-209980.
]Search in Google Scholar
[
22. Garcia-Vidal C, Meira F, Cózar-Llistó A et al. COVID19-researcher group. Real-life use of remdesivir in hospitalized patients with COVID-19. Rev Esp Quimioter. 2021; 34 (2): 136-140. doi: 10.37201/req/018.2021
]Search in Google Scholar
[
23. McPadden J, Warner F, Young HP et al. Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection. PLoS One. 2021; 16(3):e0243291. doi: 10.1371/journal. pone.0243291. eCollection 2021.
]Search in Google Scholar
[
24. Efficace F, Breccia M, Fazi P et al. The GIMEMA-ALLIANCE Digital Health Platform for Patients With Hematologic Malignancies in the COVID-19 Pandemic and Postpandemic Era: Protocol for a Multicenter, Prospective, Observational Study. JMIR Res Protoc. 2021; 10(6):e25271. doi: 10.2196/25271.
]Search in Google Scholar
[
25. Denis F, Septans A-L, Periers L et al. Olfactory Training and Visual Stimulation Assisted by a Web Application for Patients With Persistent Olfactory Dysfunction After SARS-CoV-2 Infection: Observational Study. J Med Internet Res. 2021; 23(5):e29583. doi: 10.2196/29583.
]Search in Google Scholar
[
26. Caruso С, Colantuono S, Urbani S et al. Real-life survey on severe asthma patients during COVID-19 lockdown in Italy. Expert Rev Respir Med. 2021; 1-4. doi: 10.1080/17476348.2021.1917387.
]Search in Google Scholar
[
27. Maláska J, Stašek J, Duška F, REMED Study Group. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial. Trials. 2021; 22 (1): 172. doi: 10.1186/s13063-021-05116-9
]Search in Google Scholar
[
28. Kelleni MT. NSAIDs/nitazoxanide/azithromycin repurposed for COVID-19: potential mitigation of the cytokine storm interleukin-6 amplifier via immunomodulatory effects. Expert Rev Anti Infect Ther. 2021; 1-5. doi: 10.1080/14787210.2021.1939683.
]Search in Google Scholar
[
29. Nayak MK, Panda SK, Panda SS et al. Neonatal outcomes of pregnant women with COVID-19 in a developing country setup. Pediatr Neonatol. 2021 May 18;S1875-9572(21)00084-X. doi: 10.1016/j.pedneo.2021.05.004.
]Search in Google Scholar
[
30. Di Castelnuovo A, Costanzo S, Antinori A et al. COVID-19 RISK and Treatments (CORIST) Collaboration. Lopinavir/ Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study. Front Med (Lausanne). 2021; 8: 639970. doi: 10.3389/fmed.2021.639970. eCollection 2021.
]Search in Google Scholar
[
31. Prasad A, Yankappa N, Kumar P et al. Excretion of SARSCoV- 2 in breast milk: a single-centre observational study. BMJ Paediatr Open. 2021; 5(1):e001087. doi: 10.1136/bmjpo-2021-001087. eCollection 2021
]Search in Google Scholar
[
32. van Hensbergen M, Casper D J den Heijer, Wolffs P et al. COVID-19: first long-term care facility outbreak in the Netherlands following cross-border introduction from Germany, March 2020 BMC Infect Dis. 2021 May 4;21(1):418. doi: 10.1186/s12879-021-06093-9.
]Search in Google Scholar
[
33. Byttebier G, Belmans L, Alexander M et al. Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs. Hum Vaccin Immunother. 2021,28;1-10. doi: 10.1080/21645515.2021.1920271. Online ahead of print.
]Search in Google Scholar
[
34. Lebourgeois S, Storto A, Gout B et alux. Performance evaluation of the QIAstat-Dx® Respiratory SARS-CoV-2 Panel. Int J Infect Dis. 2021;107:179-181. doi: 10.1016/j.ijid.2021.04.066.
]Search in Google Scholar
